Hereditary hemochromatosis
Information
- Disease name
- Hereditary hemochromatosis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03395704 | Completed | Phase 2 | A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis | November 29, 2017 | October 28, 2019 |
| NCT00395629 | Completed | Phase 1/Phase 2 | Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis | August 2006 | March 2009 |
| NCT00440986 | Completed | Phase 2/Phase 3 | Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis | April 2003 | December 2006 |
| NCT00068159 | Completed | Cardiac Function in Patients With Hereditary Hemochromatosis | December 8, 2003 | July 6, 2022 | |
| NCT04202965 | Completed | Phase 2 | PTG-300 in Subjects With Hereditary Hemochromatosis | March 19, 2020 | February 15, 2022 |
| NCT05742035 | Enrolling by invitation | N/A | Quality and Biologic Characteristics of Red Blood Concentrates Obtained From Individuals With Elevated Ferritin. | January 18, 2023 | March 31, 2024 |
| NCT03203850 | Terminated | Phase 2 | Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH) | January 11, 2018 | April 17, 2023 |
| NCT05238207 | Terminated | Phase 1 | A Study to Evaluate BBI-001 in Hereditary Haemochromatosis (HH) Patients and Iron Deficient Volunteers | March 28, 2022 | May 4, 2023 |
| NCT01398644 | Unknown status | Phase 3 | Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients | May 2008 | December 2013 |
- MedGen concept unique identifier (MedGen Concept name)
- C0392514
- MedGen unique identifier (MedGen Concept name)
- 140272